GRP
NUVB icon

Global Retirement Partners’s Nuvation Bio NUVB Stock Holding History

Global Retirement Partners’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,610
Closed -$3.69K – 3745
2024
Q3 		$3.69K Buy
+1,610
New +$4.91K ﹤0.01% 2697
2023
Q4 		– Sell
-410
Closed -$508 – 3442
2023
Q3 		$508 Buy
+410
New +$682 ﹤0.01% 2953

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

Global Retirement Partners's NUVB Position: Q4 2024 in Review

Global Retirement Partners sold out of Nuvation Bio (NUVB) in Q4 2024, closing a stake of 1,610 shares — an estimated $3.69K sold.

Global Retirement Partners first reported a position in NUVB in Q3 2023 and held it in 2 quarters. The position peaked at $3.69K in Q3 2024. 160 funds tracked by Wall St. Rank hold NUVB as of Q4 2024.

  • Global Retirement Partners reported no remaining Nuvation Bio position as of Q4 2024 after selling out during the quarter.
  • Global Retirement Partners sold 1,610 Nuvation Bio shares in Q4 2024, an estimated $3.69K.
  • Global Retirement Partners first reported a position in Nuvation Bio in Q3 2023 and held it in 2 quarters.
  • Global Retirement Partners's Nuvation Bio position peaked at $3.69K in Q3 2024.
  • 160 funds tracked by Wall St. Rank held Nuvation Bio as of Q4 2024.

Based on Global Retirement Partners's 13F filing for Q4 2024, filed 31 Jan 2025.